These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 10406061

  • 1. Value of radiation therapy in the management of chemoresistant intermediate grade non-Hodgkin's lymphoma.
    Aref A, Narayan S, Tekyi-Mensah S, Varterasian M, Dan M, Eilender D, Karanes C, al-Katib A.
    Radiat Oncol Investig; 1999; 7(3):186-91. PubMed ID: 10406061
    [Abstract] [Full Text] [Related]

  • 2. Results of radiotherapy and combined modality treatment in early stage high grade non-Hodgkin's lymphoma.
    Frank C, Flentje M, Goldschmidt H, Hunstein W, Wannenmacher M.
    Strahlenther Onkol; 1994 Jul; 170(7):383-90. PubMed ID: 8052937
    [Abstract] [Full Text] [Related]

  • 3. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB.
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [Abstract] [Full Text] [Related]

  • 4. Treatment results of tonsillar lymphoma: a 10-year experience.
    Mohammadianpanah M, Omidvai S, Mosalei A, Ahmadloo N.
    Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
    [Abstract] [Full Text] [Related]

  • 5. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
    Seymour JF, Pro B, Fuller LM, Manning JT, Hagemeister FB, Romaguera J, Rodriguez MA, Ha CS, Smith TL, Ayala A, Hess M, Cox JD, Cabanillas F, McLaughlin P.
    J Clin Oncol; 2003 Jun 01; 21(11):2115-22. PubMed ID: 12775737
    [Abstract] [Full Text] [Related]

  • 6. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
    Dawson LA, Saito NG, Ratanatharathorn V, Uberti JP, Adams PT, Ayash LJ, Reynolds CM, Silver SM, Schipper MJ, Lichter AS, Eisbruch A.
    Int J Radiat Oncol Biol Phys; 2004 May 01; 59(1):208-18. PubMed ID: 15093918
    [Abstract] [Full Text] [Related]

  • 7. Outcome of hyperfractionated radiotherapy in chemotherapy-resistant non-Hodgkin's lymphoma.
    Martens C, Hodgson DC, Wells WA, Sun A, Bezjak A, Pintilie M, Crump M, Gospodarowicz MK, Tsang R.
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1183-7. PubMed ID: 16376490
    [Abstract] [Full Text] [Related]

  • 8. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.
    Philip T, Armitage JO, Spitzer G, Chauvin F, Jagannath S, Cahn JY, Colombat P, Goldstone AH, Gorin NC, Flesh M.
    N Engl J Med; 1987 Jun 11; 316(24):1493-8. PubMed ID: 3295541
    [Abstract] [Full Text] [Related]

  • 9. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR, Zhang YJ, Xie FY, Zheng W, Li HX, Xia YF, Lin TY, Lu TX.
    Ai Zheng; 2006 Dec 11; 25(12):1543-9. PubMed ID: 17166383
    [Abstract] [Full Text] [Related]

  • 10. High-dose carmustine, etoposide, and cisplatin for autologous stem cell transplantation with or without involved-field radiation for relapsed/refractory lymphoma: an effective regimen with low morbidity and mortality.
    Wadhwa PD, Fu P, Koc ON, Cooper BW, Fox RM, Creger RJ, Bajor DL, Bedi T, Laughlin MJ, Payne J, Gerson SL, Lazarus HM.
    Biol Blood Marrow Transplant; 2005 Jan 11; 11(1):13-22. PubMed ID: 15625540
    [Abstract] [Full Text] [Related]

  • 11. [Treatment effect of DICE regimen on patients with relapsed or refractory intermediate and high grade non-Hodgkin's lymphoma].
    Zhou SY, Shi YK, He XH, Zhang P, Dong M, Huang DZ, Yang JL, Zhang CG, Liu P, Yang S, Feng FY.
    Ai Zheng; 2005 Apr 11; 24(4):465-9. PubMed ID: 15820071
    [Abstract] [Full Text] [Related]

  • 12. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM).
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206
    [Abstract] [Full Text] [Related]

  • 13. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
    Yao B, Li YX, Fang H, Jin J, Liu XF, Yu ZH.
    Ai Zheng; 2006 Apr 15; 25(4):465-70. PubMed ID: 16613682
    [Abstract] [Full Text] [Related]

  • 14. Long-term outcome of localized high-grade non-Hodgkin's lymphoma treated with high dose CHOP regimen and involved field radiotherapy: results of a GOELAMS study.
    Bernard M, Cartron G, Rachieru P, LeMevel A, Branger B, Le Maignan C, Berthou C, Ghandour C, Delwail V, Milpied N, Cassasus P, Celigny PS, Guyotat D, Lamy T, Desablens B, French GOELAMS Group.
    Haematologica; 2005 Jun 15; 90(6):802-9. PubMed ID: 15951293
    [Abstract] [Full Text] [Related]

  • 15. Treatment outcome and prognostic factors for relapse after high-dose chemotherapy and peripheral blood stem cell rescue for patients with poor risk high grade non-Hodgkin's lymphoma.
    Lee SM, Ryder WD, Clemons MJ, Morgenstern GR, Chang J, Scarffe JH, Radford JA.
    Bone Marrow Transplant; 1999 Aug 15; 24(3):271-7. PubMed ID: 10455365
    [Abstract] [Full Text] [Related]

  • 16. A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL).
    Gobbi PG, Ghirardelli ML, Avanzini P, Baldini L, Quarta G, Stelitano C, Broglia C, Loni C, Silingardi V, Ascari E.
    Haematologica; 2000 Mar 15; 85(3):263-8. PubMed ID: 10702814
    [Abstract] [Full Text] [Related]

  • 17. 'Relative' chemotherapy sensitivity: the impact of number of salvage regimens prior to autologous stem cell transplant for relapsed and refractory aggressive non-Hodgkin's lymphoma.
    Chen CI, Roitman D, Tsang R, Stewart AK, Keating A, Crump M.
    Bone Marrow Transplant; 2002 Dec 15; 30(12):885-91. PubMed ID: 12476281
    [Abstract] [Full Text] [Related]

  • 18. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
    Guo Y, Lu JJ, Ma X, Wang B, Hong X, Li X, Li J.
    Oral Oncol; 2008 Jan 15; 44(1):23-30. PubMed ID: 17306611
    [Abstract] [Full Text] [Related]

  • 19. Radiotherapy for localized relapse in patients with non-Hodgkin's lymphoma: a preliminary report.
    Nakamura K, Kunitake N, Kimura M, Shioyama Y, Terashima H, Masuda K.
    Radiat Med; 2000 Jan 15; 18(4):245-8. PubMed ID: 11247000
    [Abstract] [Full Text] [Related]

  • 20. [The role of radiation therapy in the management of non-Hodgkin's lymphoma].
    Masaki N.
    Gan No Rinsho; 1988 Apr 15; 34(5):573-80. PubMed ID: 3385923
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.